Asco University Weekly Podcasts
Cancer Topics - Recent Approvals: Erdafitinib and Enfortumab for Second-Line Treatment of Metastatic Bladder Cancer
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:05:39
- Mais informações
Informações:
Sinopse
Dr. Winston Tan, Medical Oncologist at Mayo Clinic, discusses the recent FDA approval of erdafitinib and enfortumab for second-line treatment of metastatic bladder cancer.
